MENU
+Compare
DBVT
Stock ticker: NASDAQ
AS OF
Apr 2 closing price
Price
$7.70
Change
+$1.24 (+19.20%)
Capitalization
127.62M

DBVT DBV Technologies S.A Forecast, Technical & Fundamental Analysis

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin... Show more

Industry: #Biotechnology
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DBVT with price predictions
Apr 02, 2025

DBVT's RSI Indicator reaches overbought territory

The RSI Oscillator for DBVT moved into overbought territory on April 02, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBVT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DBVT broke above its upper Bollinger Band on April 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 28, 2025. You may want to consider a long position or call options on DBVT as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DBVT just turned positive on March 28, 2025. Looking at past instances where DBVT's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

DBVT moved above its 50-day moving average on March 28, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for DBVT moved above the 200-day moving average on March 07, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +7 3-day Advance, the price is estimated to grow further. Considering data from situations where DBVT advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 77 cases where DBVT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DBVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.767) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (75.432) is also within normal values, averaging (252.036).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DBVT is expected to report earnings to fall 32.14% to -18 cents per share on July 29

DBV Technologies S.A DBVT Stock Earnings Reports
Q2'24
Est.
$-0.19
Q1'24
Missed
by $0.05
Q4'23
Beat
by $0.02
Q3'23
Beat
by $0.07
Q2'23
Missed
by $0.05
The last earnings report on May 07 showed earnings per share of -28 cents, missing the estimate of -23 cents. With 489.13K shares outstanding, the current market capitalization sits at 127.62M.
A.I. Advisor
published General Information

General Information

a developer of non invasive epicutaneous diagnostics systems and immunotherapy for allergy diagnostics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
177-181 avenue Pierre Brossolette
Phone
+33 155427878
Employees
104
Web
http://www.dbvtechnologies.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGICX17.36N/A
N/A
Virtus KAR Equity Income C
VMNFX13.27N/A
N/A
Vanguard Market Neutral Inv
FSANX15.52N/A
N/A
Fidelity Asset Manager 60%
SPMHX9.19N/A
N/A
Invesco SteelPath MLP Alpha R5
PVETX16.87N/A
N/A
PACE Small/Medium Co Val Eq P2

DBVT and Stocks

Correlation & Price change

A.I.dvisor tells us that DBVT and CRDF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBVT and CRDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
+19.20%
CRDF - DBVT
32%
Poorly correlated
-1.63%
DTIL - DBVT
31%
Poorly correlated
+4.45%
SNPX - DBVT
29%
Poorly correlated
-2.56%
GLSI - DBVT
29%
Poorly correlated
+0.97%
PASG - DBVT
26%
Poorly correlated
+1.30%
More